Aligned Genetics (238120.KQ) Stock Price

Aligned Genetics Price

CLOSED
2,440.00
​
Market closed

Revenue has compounded at 21.1% per year over the past 12 years to 16.02 B KRW. Earnings per share have grown at 70.9% per year over the last 6 years. Aligned Genetics's net margin stands at 18.2%, down from 47.1% several years earlier.

Aligned Genetics stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Aligned Genetics business model & stock analysis

Aligned Genetics Inc, based in Anyang, South Korea, operates in the Health Care sector within the Life Sciences Tools & Services industry. The company commercializes innovative products for life science research, including automated cell counters like LUNA and LUNA-FL, tissue clearing systems such as X-CLARITY, and digital cell imaging systems like iRiS. Listed on November 3, 2016, it serves the global research community with advanced laboratory solutions.

Frequently asked questions about Aligned Genetics

5 analysts currently rate the Aligned Genetics stock: 4 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Aligned Genetics share trades at 1.64 EUR (2,440.00 KRW).

The revenue cannot currently be calculated for Aligned Genetics.

The profit cannot currently be calculated for Aligned Genetics.

The P/E ratio cannot be calculated for Aligned Genetics at the moment.

The P/S cannot be calculated for Aligned Genetics currently.

The Eulerpool Quality Score for Aligned Genetics is 4/10.

The ISIN of Aligned Genetics is KR7238120000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Aligned Genetics is 238120.KQ. The ticker symbol is used to trade Aligned Genetics shares on the stock exchange.

Fair ValueTerminal
2,074.00 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Nov 3, 2016
ISIN
KR7238120000
Cusip
Y5S122103
Market capitalization
35.08 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
13.23
P/B Ratio
0.94
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
5.94 %
Last updated Oct 31, 2026, 3:51 PM

Aligned Genetics Peer Group

Aligned Genetics FIGI

238120:KS · BBG00DW1LJ53238120:KQ · BBG00DW1LJ71